Diverse fusion patterns and heterogeneous clinicopathologic features of renal cell carcinoma with t(6;11) translocation

American Journal of Surgical Pathology

Volumn 36, Issue 1, 2012, Pages 35-42

  Inamura, Kentaro ^a   Fujiwara, Mutsunori ^b   Togashi, Yuki ^a   Nomura, Kimie ^a   Mukai, Hiroyuki ^c   Fujii, Yasuhisa ^d   Yamamoto, Shinya ^d   Yonese, Junji ^d   Fukui, Iwao ^d   Ishikawa, Yuichi ^a  

^a CANCER INSTITUTE   (Japan)

^b CANCER INSTITUTE HOSPITAL   (Japan)

^c JAPANESE RED CROSS MEDICAL CENTER   (Japan)

^d FML Laboratory   (Japan)

Author keywords

MALAT1; renal cell carcinoma; TFEB; translocation

Indexed keywords

BASIC HELIX LOOP HELIX LEUCINE ZIPPER TRANSCRIPTION FACTOR; TFEB PROTEIN, HUMAN;

ADULT; ARTICLE; CASE REPORT; CHROMOSOME 11; CHROMOSOME 6; CHROMOSOME ABERRATION; GENE TRANSLOCATION; GENETICS; HUMAN; IMMUNOHISTOCHEMISTRY; KARYOTYPING; KIDNEY CARCINOMA; KIDNEY TUMOR; MALE; MIDDLE AGED; PATHOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE MICROARRAY; WESTERN BLOTTING;

ABNORMAL KARYOTYPE; ADULT; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BLOTTING, WESTERN; CARCINOMA, RENAL CELL; CHROMOSOMES, HUMAN, PAIR 11; CHROMOSOMES, HUMAN, PAIR 6; HUMANS; IMMUNOHISTOCHEMISTRY; KARYOTYPING; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TISSUE ARRAY ANALYSIS; TRANSLOCATION, GENETIC;

EID: 84255166388     PISSN: 01475185     EISSN: 15320979     Source Type: Journal    
DOI: 10.1097/PAS.0b013e3182293ec3     Document Type: Article

References (17)

1. Argani P, Hawkins A, Griffin CA, et al. A distinctive pediatric renal neoplasm characterized by epithelioid morphology, basement membrane production, focal HMB45 immunoreactivity, and t(6;11)(p21.1;q12) chromosome translocation. Am J Pathol. 2001;158:2089-2096. (Pubitemid 32545194)
2. Argani P, Lae M, Hutchinson B, et al. Renal carcinomas with the t(6;11)(p21;q12): clinicopathologic features and demonstration of the specific alpha-TFEB gene fusion by immunohistochemistry, RT-PCR, and DNA PCR. Am J Surg Pathol. 2005;29:230-240. (Pubitemid 40170642)
3. Argani P, Lae M, Ballard ET, et al. Translocation carcinomas of the kidney after chemotherapy in childhood. J Clin Oncol. 2006;24: 1529-1534. (Pubitemid 46638774)
4. Argani P, Hicks J, De Marzo AM, et al. Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers. Am J Surg Pathol. 2010;34:1295-1303.
5. Camparo P, Vasiliu V, Molinie V, et al. Renal translocation carcinomas: clinicopathologic, immunohistochemical, and gene expression profiling analysis of 31 cases with a review of the literature. Am J Surg Pathol. 2008;32:656-670. (Pubitemid 351600831)
6. Davis IJ, Hsi BL, Arroyo JD, et al. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. Proc Natl Acad Sci USA. 2003;100:6051-6056. (Pubitemid 36576929)
7. Eble JN, Sauter G, Epstein JI, et al, ed. World Health Organization Classification of Tumours: Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs. Lyon: IARC press; 2004.
8. Geller JI, Argani P, Adeniran A, et al. Translocation renal cell carcinoma: lack of negative impact due to lymph node spread. Cancer. 2008;112:1607-1616. (Pubitemid 351441175)
9. Hora M, Hes O, Urge T, et al. A distinctive translocation carcinoma of the kidney "rosette-like forming," t(6;11), HMB45-positive renal tumor. Int Urol Nephrol. 2009;41:553-557.
10. Komai Y, Fujiwara M, Fujii Y, et al. Adult Xp11 translocation renal cell carcinoma diagnosed by cytogenetics and immunohisto-chemistry. Clin Cancer Res. 2009;15:1170-1176.
11. Kuiper RP, Schepens M, Thijssen J, et al. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum Mol Genet. 2003;12:1661-1669. (Pubitemid 36896659)
12. Martignoni G, Tardanico R, Pea M, et al. t(6;11) renal cell tumor: a clinicopathological study of two cases in adults (abstr 715). Mod Pathol. 2005;18:155A.
13. Martignoni G, Pea M, Gobbo S, et al. Cathepsin-K immunor-eactivity distinguishes MiTF/TFE family renal translocation carcinomas from other renal carcinomas. Mod Pathol. 2009;22:1016-1022.
14. Martignoni G, Gobbo S, Camparo P, et al. Differential expression of cathepsin K in neoplasms harboring TFE3 gene fusions. Mod Pathol. 2011. DOI: 10.1038/modpathol.2011.93.
15. Pecciarini L, Cangi MG, Lo Cunsolo C, et al. Characterization of t(6;11)(p21;q12) in a renal-cell carcinoma of an adult patient. Genes Chromosomes Cancer. 2007;46:419-426. (Pubitemid 46449244)
16. Suarez-Vilela D, Izquierdo-Garcia F, Mendez-Alvarez JR, et al. Renal Translocation Carcinoma With Expression of TFEB: Presentation of a Case With Distinctive Histological and Immuno-histochemical Features. Int J Surg Pathol. 2009. DOI:10.1177/1066896909340531.
17. Zhan HQ, Wang CF, Zhu XZ, et al. Renal cell carcinoma with t(6;11) translocation: a patient case with a novel Alpha-TFEB fusion point. J Clin Oncol. 2010;28:e709-713.